188 related articles for article (PubMed ID: 10680011)
21. Lentivirus vectors: difficulties and hopes before clinical trials.
Kafri T
Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
24. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
25. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
26. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
Copreni E; Penzo M; Carrabino S; Conese M
Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
28. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.
D'Costa J; Harvey-White J; Qasba P; Limaye A; Kaneski CR; Davis-Warren A; Brady RO; Bankiewicz KS; Major EO; Arya SK
J Med Virol; 2003 Oct; 71(2):173-82. PubMed ID: 12938190
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy in the CNS.
Costantini LC; Bakowska JC; Breakefield XO; Isacson O
Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 (HIV-1) derived vectors: safety considerations and controversy over therapeutic applications.
Romano G; Claudio PP; Tonini T; Giordano A
Eur J Dermatol; 2003; 13(5):424-9. PubMed ID: 14693483
[TBL] [Abstract][Full Text] [Related]
32. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
[TBL] [Abstract][Full Text] [Related]
34. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
35. Stable transduction of primary human monocytes by simian lentiviral vector PBj.
Mühlebach MD; Wolfrum N; Schüle S; Tschulena U; Sanzenbacher R; Flory E; Cichutek K; Schweizer M
Mol Ther; 2005 Dec; 12(6):1206-16. PubMed ID: 16150648
[TBL] [Abstract][Full Text] [Related]
36. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.
Deroose CM; Reumers V; Gijsbers R; Bormans G; Debyser Z; Mortelmans L; Baekelandt V
Mol Ther; 2006 Sep; 14(3):423-31. PubMed ID: 16820324
[TBL] [Abstract][Full Text] [Related]
38. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
Segura MM; Kamen A; Garnier A
Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
[TBL] [Abstract][Full Text] [Related]
39. GFP-lentiviral vectors targeting for neuroAIDS.
Lu Y
Methods Mol Biol; 2009; 515():177-97. PubMed ID: 19378133
[TBL] [Abstract][Full Text] [Related]
40. Harnessing HIV for therapy, basic research and biotechnology.
Wiznerowicz M; Trono D
Trends Biotechnol; 2005 Jan; 23(1):42-7. PubMed ID: 15629857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
